Selected Publications and Presentations

Modified

September 24, 2026

A list of select publications and presentations that I supported in my work at SCRI and Fred Hutch. I am first author of a research journal article on CBFA2T3-GLIS pediatric AML (pAML) patients and co-first author for a research article on NUP98-rearranged pAML.

I assisted with a large part of the data analysis/processing, figure generation, and manuscript writing on these publications.

The Data Viz section is an overview some of the figures generated for publications I supported.

  • Zanghí, G.*, Patel, H.*, Smith, J.L.*, .. Vaughan, A. M. and Kappe, S. H. I.. Genome-wide gene expression profiles throughout human malaria parasite liver stage development in humanized mice. Nature Microbiology. 2025. DOI:https://doi.org/10.1038/s41564-024-01905-5

  • Bertrums, E. J. M.*,Smith, J. L.* , Harmon, L.*, … Meshinchi, S. Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia. Haematologica. 2023. DOI:10.3324/haematol.2022.281653

  • Farrar, J. E., Smith, J. L., … Meshinchi, S. Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia. Journal of Clinical Oncology. 2023. DOI:10.1200/jco.22.01114

  • Chisholm, K. M., Smith, J., Heerema-McKenney, A. E., … Meshinchi, S., & Kahwash, S. B. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children’s Oncology Group. Pediatric blood & cancer. 2023 DOI:10.1002/pbc.30251

  • Huang, B.J., Smith, J.L., Farrar, J.E. … Meshinchi, S. Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia. Nature Communications. 2022. DOI:10.1038/s41467-022-33244-6

  • Le, Q., Hadland, B., Smith, J. L., … Meshinchi, S. CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target. Journal of Clinical Investigation. 2022. DOI:10.1172/jci157101

  • Huang, B., Smith, J. L., Wang, J., … Meshinchi, S. CBFB-MYH11 Fusion Transcripts Distinguish Acute Myeloid Leukemias with Distinct Molecular Landscapes and Outcomes. Blood Advances 2021. DOI:10.1182/bloodadvances.2021004965

  • Chisholm, K., Heerema-McKenney, A., Choi, J., Smith, J.L. … Kahwash, B. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children’s Oncology Group. Blood Advances 2020. DOI:10.1182/bloodadvances.2020002712

  • Noort, S., Wander, P., Alonzo, T. A., Smith, J.L., … Meshinchi, S. The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia. Haematologica 2020. DOI:10.3324/haematol.2019.236745

  • Smith, J. L., Ries, R. E., Hylkema, T., Alonzo, T. A, … Meshinchi, S. Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-positive AML Defines Novel Therapeutic Options – A COG and TARGET Pediatric AML Study. Clinical Cancer Research 2019. DOI:10.1158/1078-0432.CCR-19-1800

  • Noort, S., Zimmermann, M., Reinhardt, D., Cuccuini, W., Pigazzi, M., Smith, J., … Zwaan, C. M. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group. Blood 2018. DOI:10.1182/blood-2018-05-849059

* Indicates co-first authorship

Additional Publications

  • IGNITE, panelist on careers in data science and technology to promote gender equity and representation in STEM. IGNITE Field Trip with Rainier Beach High School (Seattle Children’s Research Institute, Seattle, WA, 2024). link

  • Molecular Medicine Tri-conference, panelist on AI in Genomics and Precision Medicine (San Francisco, CA, 2020). link.

  • American Society for Hematology, poster on Long Non-Coding RNAs (lncRNAs) Are Highly Associated with Disease Characteristics and Outcome in Pediatric Acute Myeloid Leukemia - a COG and Tpaml Study (Orlando, FL, 2019). DOI.

  • Brotman Baty Pediatric Sequencing Symposium, oral presentation on Long Non-coding RNAs Associate with Outcome in Pediatric Acute Myeloid Leukemia (Seattle, WA, 2019).

  • American Society for Hematology, oral presentation on Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options — a COG and Target Pediatric AML Study (San Diego, CA, 2018). DOI.

  • American Society for Hematology, oral presentation on The LSC17 Leukemic Stem Cell Signature Predicts Outcome in Pediatric Acute Myeloid Leukemia. Abstract Achievement Award Recipient (Atlanta, GA, 2017). link

Other Presentations

  • American Society for Hematology, poster on ETS Family Transcription Factor Fusions in Childhood AML: Distinct Expression Networks and Clinical Implications (Virtual, 2021). DOI.

  • American Society for Hematology, poster on The Transcriptomic Landscape of NUP98-Rearranged Pediatric Acute Myeloid Leukemia (Virtual, 2020).DOI.